FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christine Damm-Welk

Research Profile

Chemicals & Drugs

Disorders

Procedures

Anatomy

Concepts & Ideas

Survival Analysis

Genes & Molecular Sequences

Genes, Immunoglobulin Heavy Chain

Co-author Network

Publications

TOP 3
Lara Mussolin; Marta Pillon; K Pulford; Alfred Reiter; Angelo Rosolen; Christine Damm-Welk; G Franceschetto; Martin Zimmermann; Willi Woessmann
Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis.
Itziar Salaverria; Monika Szczepanowski; Takashi Akasaka; Birgit Burkhardt; Christine Damm-Welk; Martin J S Dyer; Stefan Gesk; Lana Harder; Wolfram Klapper; Ilske Oschlies; Reiner Siebert
The CBFA2T3/ACSF3 locus is recurrently involved in IGH chromosomal translocation t(14;16)(q32;q24) in pediatric B-cell lymphoma with germinal center phenotype.
Leandro Cerchietti; Christine Damm-Welk; Inga Vater; Wolfram Klapper; Lana Harder; Christiane Pott; Shao Ning Yang; Alfred Reiter; Reiner Siebert; Ari Melnick; Willi Woessmann
Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christine Damm-Welk (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lara Mussolin; Marta Pillon; K Pulford; Alfred Reiter; Angelo Rosolen; Christine Damm-Welk; G Franceschetto; Martin Zimmermann; Willi Woessmann
Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis.
Leukemia 2013;27(2):416-22.
2012: Itziar Salaverria; Monika Szczepanowski; Takashi Akasaka; Birgit Burkhardt; Christine Damm-Welk; Martin J S Dyer; Stefan Gesk; Lana Harder; Wolfram Klapper; Ilske Oschlies; Reiner Siebert
The CBFA2T3/ACSF3 locus is recurrently involved in IGH chromosomal translocation t(14;16)(q32;q24) in pediatric B-cell lymphoma with germinal center phenotype.
Genes, chromosomes & cancer 2012;51(4):338-43.
2011: Leandro Cerchietti; Christine Damm-Welk; Inga Vater; Wolfram Klapper; Lana Harder; Christiane Pott; Shao Ning Yang; Alfred Reiter; Reiner Siebert; Ari Melnick; Willi Woessmann
Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas.
PloS one 2011;6(4):e18436.
2009: Christine Damm-Welk; Wolfram Klapper; Ilske Oschlies; Stefan Gesk; Silja Röttgers; Jutta Bradtke; Reiner Siebert; Alfred Reiter; Willi Woessmann
Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation.
British journal of haematology 2009;146(3):306-9.
2008: Birgit Burkhardt; Anja Moericke; Wolfram Klapper; Franziska Greene; Janina Salzburg; Christine Damm-Welk; Martin Zimmermann; Konstantin Strauch; Wolf-Dieter Ludwig; Martin Schrappe; Alfred Reiter
Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact.
Leukemia & lymphoma 2008;49(3):451-61.
2007: Christine Damm-Welk; Jutta Schieferstein; Simone Schwalm; Alfred Reiter; Willi Woessmann
Flow cytometric detection of circulating tumour cells in nucleophosmin/anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: comparison with quantitative polymerase chain reaction.
British journal of haematology 2007;138(4):459-66.
2007: Christine Damm-Welk; Kerstin Busch; Birgit Burkhardt; Jutta Schieferstein; Susanne Viehmann; Ilske Oschlies; Wolfram Klapper; Martin Zimmermann; Jochen Harbott; Alfred Reiter; Willi Woessmann
Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK-positive anaplastic large-cell lymphoma.
Blood 2007;110(2):670-7.
2004: Uta Fuchs; Christine Damm-Welk; Arndt Borkhardt
Silencing of disease-related genes by small interfering RNAs.
Current molecular medicine 2004;4(5):507-17.
2003: Willi Woessmann; Christine Damm-Welk; Uta Fuchs; Arndt Borkhardt
RNA interference: new mechanisms for targeted treatment?
Reviews in clinical and experimental hematology 2003;7(3):270-91.
2003: Christine Damm-Welk; Uta Fuchs; Wilhelm Wössmann; Arndt Borkhardt
Targeting oncogenic fusion genes in leukemias and lymphomas by RNA interference.
Seminars in cancer biology 2003;13(4):283-92.
2003: U Ritter; Christine Damm-Welk; Uta Fuchs; RM Bohle; Arndt Borkhardt; Willi Woessmann
Design and evaluation of chemically synthesized siRNA targeting the NPM-ALK fusion site in anaplastic large cell lymphoma (ALCL).
Oligonucleotides 2003;13(5):365-73.
2001: Uta Fuchs; G Rehkamp; Oskar A Haas; Robert K Slany; M Kōnig; SE Bojesen; RM Bohle; Christine Damm-Welk; Wolf-Dieter Ludwig; Jochen Harbott; Arndt Borkhardt
The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(15):8756-61.